Clear Street’s Translational Development Acquisition Corp Units TDACU Stock Holding History

Clear Street’s Portfolio TDACU Stock Details TDACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$140K	Buy	+12,344	New	+$152K	﹤0.01%	777
2025 Q2	–	Sell	-15,918	Closed	-$161K	–	744
2025 Q1	$161K	Sell	15,918 -42,982	-73%	-$434K	﹤0.01%	99
2024 Q4	$590K	Buy	+58,900	New	+$590K	0.01%	67

Other funds holding TDACU

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Clear Street's TDACU Position: Q2 2026 in Review

Clear Street opened a new position in Translational Development Acquisition Corp Units (TDACU) in Q2 2026: 12,344 shares worth $140K. The stake represents ﹤0.01% of the portfolio and ranks #777 among its holdings. This is a return to the name: Clear Street previously reported a position in TDACU as recently as Q1 2025.

Clear Street first reported a position in TDACU in Q4 2024 and has held it in 3 quarters since. The position peaked at $590K in Q4 2024. 3 funds tracked by Wall St. Rank hold TDACU as of Q2 2026.

Clear Street held 12,344 shares of Translational Development Acquisition Corp Units worth $140K as of Q2 2026.
Translational Development Acquisition Corp Units was a new Clear Street position in Q2 2026.
Translational Development Acquisition Corp Units made up ﹤0.01% of Clear Street's portfolio in Q2 2026, its #777 holding.
Clear Street first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and has held it in 3 quarters since.
Clear Street's Translational Development Acquisition Corp Units position peaked at $590K in Q4 2024.
3 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q2 2026.

Based on Clear Street's 13F filing for Q2 2026, filed 12 Aug 2026.